Pharmacyte Biotech, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed by Pharmacyte Biotech, Inc. on June 21, 2021, reporting events occurring on June 18, 2021. The company is incorporated in Nevada and maintains its principal executive offices in Laguna Hills, California.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on corporate governance events rather than financial performance.
Material Changes
The primary event reported is the adjournment of the company's Annual Meeting of Stockholders. Originally held virtually on June 16, 2021, the meeting was adjourned to June 30, 2021, at 11:00 A.M. PDT. The adjournment was necessitated to allow additional time for stockholders to vote on Proposal No. 2, which seeks to increase the authorized number of shares of capital stock.
Guidance, Outlook, and Risks
The filing does not contain forward-looking guidance, management commentary on financial outlook, or specific risk factors beyond the procedural delay in the shareholder vote. The reconvened meeting will continue to be held virtually.
Key Facts for Investor Verification
- The Annual Meeting of Stockholders was adjourned from June 16, 2021, to June 30, 2021.
- The delay was specifically to facilitate voting on the proposal to increase authorized capital stock.
- The meeting remains a virtual event accessible via the company's designated shareholder portal.
- No financial data or operational metrics are disclosed in this specific filing.